{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T01:54:48Z","timestamp":1792979688205,"version":"4.5.0"},"reference-count":92,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T00:00:00Z","timestamp":1787702400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2025-23323505"],"award-info":[{"award-number":["RS-2025-23323505"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2025-02216753"],"award-info":[{"award-number":["RS-2025-02216753"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2026-25473498"],"award-info":[{"award-number":["RS-2026-25473498"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.bbcan.2026.189694","type":"journal-article","created":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T23:37:54Z","timestamp":1787701074000},"page":"189694","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Sex hormone-binding globulin as a context-dependent regulator of sex steroid bioavailability in cancers"],"prefix":"10.1016","volume":"1881","author":[{"given":"Sang R.","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eui-Ju","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bbcan.2026.189694_bb0005","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1210\/jcem-53-1-58","article-title":"Transport of steroid hormones: binding of 21 endogenous steroids to both testosterone-binding globulin and corticosteroid-binding globulin in human plasma","volume":"53","author":"Dunn","year":"1981","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bbcan.2026.189694_bb0010","doi-asserted-by":"crossref","DOI":"10.1038\/srep35539","article-title":"Sex hormone-binding globulin regulation of androgen bioactivity in vivo: validation of the free hormone hypothesis","volume":"6","author":"Laurent","year":"2016","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.bbcan.2026.189694_bb0015","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.cell.2005.06.032","article-title":"Role of endocytosis in cellular uptake of sex steroids","volume":"122","author":"Hammes","year":"2005","journal-title":"Cell"},{"issue":"1\u20136","key":"10.1016\/j.bbcan.2026.189694_bb0020","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S0960-0760(99)00070-9","article-title":"Sex hormone-binding globulin mediates steroid hormone signal transduction at the plasma membrane","volume":"69","author":"Rosner","year":"1999","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189694_bb0025","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S0889-8545(02)00008-6","article-title":"Access of reproductive steroids to target tissues","volume":"29","author":"Hammond","year":"2002","journal-title":"Obstet. Gynecol. Clin. N. Am."},{"issue":"23","key":"10.1016\/j.bbcan.2026.189694_bb0030","doi-asserted-by":"crossref","first-page":"15853","DOI":"10.1074\/jbc.M512370200","article-title":"Evidence that fibulin family members contribute to the steroid-dependent extravascular sequestration of sex hormone-binding globulin","volume":"281","author":"Ng","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189694_bb0035","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1095\/biolreprod.111.092593","article-title":"Diverse roles for sex hormone-binding globulin in reproduction","volume":"85","author":"Hammond","year":"2011","journal-title":"Biol. Reprod."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189694_bb0040","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1210\/mend.12.1.0050","article-title":"Human sex hormone-binding globulin gene expression in transgenic mice","volume":"12","author":"Janne","year":"1998","journal-title":"Mol. Endocrinol."},{"issue":"4","key":"10.1016\/j.bbcan.2026.189694_bb0045","first-page":"232","article-title":"Studies on prostatic cancer. I. The effect of castration, of estrogen and androgen injection on serum phosphatases in metastatic carcinoma of the prostate","volume":"22","author":"Huggins","year":"1972","journal-title":"CA Cancer J. Clin."},{"issue":"12","key":"10.1016\/j.bbcan.2026.189694_bb0050","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1056\/NEJMoa2119115","article-title":"Darolutamide and survival in metastatic, hormone-sensitive prostate cancer","volume":"386","author":"Smith","year":"2022","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.bbcan.2026.189694_bb0055","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1056\/NEJMoa1315815","article-title":"AR-V7 and resistance to enzalutamide and abiraterone in prostate cancer","volume":"371","author":"Antonarakis","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189694_bb0060","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nm.4045","article-title":"Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer","volume":"22","author":"Beltran","year":"2016","journal-title":"Nat. Med."},{"issue":"33","key":"10.1016\/j.bbcan.2026.189694_bb0065","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202400398","article-title":"UBX-390: a novel androgen receptor degrader for therapeutic intervention in prostate cancer","volume":"11","author":"Lee","year":"2024","journal-title":"Adv. Sci."},{"key":"10.1016\/j.bbcan.2026.189694_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2024.107234","article-title":"PROTACs targeting androgen receptor signaling: potential therapeutic agents for castration-resistant prostate cancer","volume":"205","author":"Zhang","year":"2024","journal-title":"Pharmacol. Res."},{"issue":"10023","key":"10.1016\/j.bbcan.2026.189694_bb0075","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/S0140-6736(15)00130-0","article-title":"Endometrial cancer","volume":"387","author":"Morice","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.bbcan.2026.189694_bb0080","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.steroids.2017.08.007","article-title":"Endometrium and steroids, a pathologic overview","volume":"126","author":"Plaza-Parrochia","year":"2017","journal-title":"Steroids"},{"issue":"2\u20133","key":"10.1016\/j.bbcan.2026.189694_bb0085","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s12672-019-0358-9","article-title":"Estrogen signaling in endometrial cancer: a Key oncogenic pathway with several open questions","volume":"10","author":"Rodriguez","year":"2019","journal-title":"Horm. Cancer"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189694_bb0090","first-page":"3","article-title":"Endometrial cancer: hormonal factors, the perimenopausal \"window of risk,\" and isoflavones","volume":"87","author":"Hale","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189694_bb0095","doi-asserted-by":"crossref","first-page":"231","DOI":"10.4331\/wjbc.v6.i3.231","article-title":"Current medical treatment of estrogen receptor-positive breast cancer","volume":"6","author":"Lumachi","year":"2015","journal-title":"World J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189694_bb0100","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/s13058-024-01902-w","article-title":"Disparities in receipt of 1-(st) line CDK4\/6 inhibitors with endocrine therapy for treatment of hormone receptor positive, HER2 negative metastatic breast cancer in the real-world setting","volume":"26","author":"Pilehvari","year":"2024","journal-title":"Breast Cancer Res."},{"issue":"21","key":"10.1016\/j.bbcan.2026.189694_bb0105","doi-asserted-by":"crossref","first-page":"3714","DOI":"10.1002\/cncr.32345","article-title":"ESR1 mutations in breast cancer","volume":"125","author":"Dustin","year":"2019","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.bbcan.2026.189694_bb0110","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/s41591-020-01168-7","article-title":"The androgen receptor is a tumor suppressor in estrogen receptor-positive breast cancer","volume":"27","author":"Hickey","year":"2021","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189694_bb0115","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ccr.2011.05.026","article-title":"Targeting androgen receptor in estrogen receptor-negative breast cancer","volume":"20","author":"Ni","year":"2011","journal-title":"Cancer Cell"},{"issue":"5834","key":"10.1016\/j.bbcan.2026.189694_bb0120","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1126\/science.1140485","article-title":"Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production","volume":"317","author":"Naugler","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.bbcan.2026.189694_bb0125","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ebiom.2018.08.043","article-title":"Androgen receptor drives hepatocellular carcinogenesis by activating enhancer of zeste homolog 2-mediated Wnt\/beta-catenin signaling","volume":"35","author":"Song","year":"2018","journal-title":"EBioMedicine"},{"issue":"5","key":"10.1016\/j.bbcan.2026.189694_bb0130","doi-asserted-by":"crossref","first-page":"437","DOI":"10.7555\/JBR.31.20170031","article-title":"Hydroxylation and sulfation of sex steroid hormones in inflammatory liver","volume":"31","author":"Lee","year":"2017","journal-title":"J. Biomed. Res."},{"issue":"20","key":"10.1016\/j.bbcan.2026.189694_bb0135","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1056\/NEJMoa1915745","article-title":"Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma","volume":"382","author":"Finn","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbcan.2026.189694_bb0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-642-82486-9_1","article-title":"Steroid-protein interactions II","volume":"27","author":"Westphal","year":"1986","journal-title":"Monogr. Endocrinol."},{"issue":"6","key":"10.1016\/j.bbcan.2026.189694_bb0145","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1111\/andr.13358","article-title":"Mendelian randomization analyses identified bioavailable testosterone mediates the effect of sex hormone-binding globulin on prostate cancer","volume":"11","author":"Wan","year":"2023","journal-title":"Andrology"},{"issue":"29","key":"10.1016\/j.bbcan.2026.189694_bb0150","doi-asserted-by":"crossref","first-page":"26618","DOI":"10.1074\/jbc.M202495200","article-title":"Sex hormone-binding globulin in the human prostate is locally synthesized and may act as an autocrine\/paracrine effector","volume":"277","author":"Hryb","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189694_bb0155","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1002\/ijc.33555","article-title":"Prospective analyses of testosterone and sex hormone-binding globulin with the risk of 19 types of cancer in men and postmenopausal women in UK Biobank","volume":"149","author":"Watts","year":"2021","journal-title":"Int. J. Cancer"},{"issue":"16","key":"10.1016\/j.bbcan.2026.189694_bb0160","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1093\/jnci\/88.16.1118","article-title":"Prospective study of sex hormone levels and risk of prostate cancer","volume":"88","author":"Gann","year":"1996","journal-title":"J. Natl. Cancer Inst."},{"issue":"10","key":"10.1016\/j.bbcan.2026.189694_bb0165","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1002\/ijc.23326","article-title":"Endogenous sex hormones and the risk of prostate cancer: a prospective study","volume":"122","author":"Weiss","year":"2008","journal-title":"Int. J. Cancer"},{"issue":"9","key":"10.1016\/j.bbcan.2026.189694_bb0170","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1038\/s41416-021-01518-3","article-title":"Testosterone, sex hormone-binding globulin, insulin-like growth factor-1 and endometrial cancer risk: observational and Mendelian randomization analyses","volume":"125","author":"Mullee","year":"2021","journal-title":"Br. J. Cancer"},{"issue":"12","key":"10.1016\/j.bbcan.2026.189694_bb0175","first-page":"1531","article-title":"Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review","volume":"11","author":"Kaaks","year":"2002","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"issue":"2","key":"10.1016\/j.bbcan.2026.189694_bb0180","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1677\/ERC-07-0064","article-title":"Endogenous sex hormones and endometrial cancer risk in women in the European Prospective Investigation into Cancer and Nutrition (EPIC)","volume":"15","author":"Allen","year":"2008","journal-title":"Endocr. Relat. Cancer"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189694_bb0185","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/ijc.33508","article-title":"The association of prediagnostic circulating levels of cardiometabolic markers, testosterone and sex hormone-binding globulin with risk of breast cancer among normal weight postmenopausal women in the UK biobank","volume":"149","author":"Arthur","year":"2021","journal-title":"Int. J. Cancer"},{"issue":"8","key":"10.1016\/j.bbcan.2026.189694_bb0190","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1002\/ijc.28528","article-title":"Premenopausal serum sex hormone levels in relation to breast cancer risk, overall and by hormone receptor status - results from the EPIC cohort","volume":"134","author":"Kaaks","year":"2014","journal-title":"Int. J. Cancer"},{"issue":"3","key":"10.1016\/j.bbcan.2026.189694_bb0195","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1002\/ijc.34026","article-title":"Mendelian randomization analyses of 23 known and suspected risk factors and biomarkers for breast cancer overall and by molecular subtypes","volume":"151","author":"Chen","year":"2022","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189694_bb0200","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0168-8278(97)80015-3","article-title":"Predictive value of serum sex hormone binding globulin for the occurrence of hepatocellular carcinoma in male patients with cirrhosis","volume":"26","author":"Ganne-Carrie","year":"1997","journal-title":"J. Hepatol."},{"issue":"2","key":"10.1016\/j.bbcan.2026.189694_bb0205","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1002\/hep.31057","article-title":"Associations between prediagnostic concentrations of circulating sex steroid hormones and liver cancer among postmenopausal women","volume":"72","author":"Petrick","year":"2020","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.bbcan.2026.189694_bb0210","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1002\/ijc.35244","article-title":"Total testosterone, sex hormone-binding globulin, and free testosterone concentrations and risk of primary liver cancer: a prospective analysis of 200,000 men and 180,000 postmenopausal women","volume":"156","author":"Watling","year":"2025","journal-title":"Int. J. Cancer"},{"issue":"2","key":"10.1016\/j.bbcan.2026.189694_bb0215","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0960-0760(03)00268-1","article-title":"Comparative studies on the regulation of insulin-like growth factor-binding protein-1 (IGFBP-1) and sex hormone-binding globulin (SHBG) production by insulin and insulin-like growth factors in human hepatoma cells","volume":"86","author":"Kalme","year":"2003","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"2","key":"10.1016\/j.bbcan.2026.189694_bb0220","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1677\/joe.0.124R001","article-title":"Effect of insulin-like growth factor-type I (IGF-I) and insulin on the secretion of sex hormone binding globulin and IGF-I binding protein (IBP-I) by human hepatoma cells","volume":"124","author":"Singh","year":"1990","journal-title":"J. Endocrinol."},{"issue":"12","key":"10.1016\/j.bbcan.2026.189694_bb0225","first-page":"3979","article-title":"Monosaccharide-induced lipogenesis regulates the human hepatic sex hormone-binding globulin gene","volume":"117","author":"Selva","year":"2007","journal-title":"J. Clin. Invest."},{"issue":"10","key":"10.1016\/j.bbcan.2026.189694_bb0230","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1530\/EC-20-0401","article-title":"The hepatic lipidome and HNF4alpha and SHBG expression in human liver","volume":"9","author":"Winters","year":"2020","journal-title":"Endocr. Connect."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189694_bb0235","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1677\/JME-09-0025","article-title":"Thyroid hormones act indirectly to increase sex hormone-binding globulin production by liver via hepatocyte nuclear factor-4alpha","volume":"43","author":"Selva","year":"2009","journal-title":"J. Mol. Endocrinol."},{"issue":"8","key":"10.1016\/j.bbcan.2026.189694_bb0240","doi-asserted-by":"crossref","first-page":"2820","DOI":"10.1210\/en.2014-1072","article-title":"Adiponectin upregulates SHBG production: molecular mechanisms and potential implications","volume":"155","author":"Simo","year":"2014","journal-title":"Endocrinology"},{"issue":"11","key":"10.1016\/j.bbcan.2026.189694_bb0245","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1210\/me.2012-1152","article-title":"IL1beta down-regulation of sex hormone-binding globulin production by decreasing HNF-4alpha via MEK-1\/2 and JNK MAPK pathways","volume":"26","author":"Simo","year":"2012","journal-title":"Mol. Endocrinol."},{"issue":"2","key":"10.1016\/j.bbcan.2026.189694_bb0250","doi-asserted-by":"crossref","first-page":"372","DOI":"10.2337\/db11-0727","article-title":"Potential role of tumor necrosis factor-alpha in downregulating sex hormone-binding globulin","volume":"61","author":"Simo","year":"2012","journal-title":"Diabetes"},{"issue":"3","key":"10.1016\/j.bbcan.2026.189694_bb0255","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1210\/me.2011-1321","article-title":"Molecular mechanism of TNFalpha-induced down-regulation of SHBG expression","volume":"26","author":"Simo","year":"2012","journal-title":"Mol. Endocrinol."},{"issue":"9","key":"10.1016\/j.bbcan.2026.189694_bb0260","doi-asserted-by":"crossref","first-page":"3598","DOI":"10.1002\/jcp.30818","article-title":"Transforming growth factor-beta 1: a new factor reducing hepatic SHBG production in liver fibrosis","volume":"237","author":"Brianso-Llort","year":"2022","journal-title":"J. Cell. Physiol."},{"issue":"6","key":"10.1016\/j.bbcan.2026.189694_bb0265","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1210\/jc.2005-2157","article-title":"Mitotane has an estrogenic effect on sex hormone-binding globulin and corticosteroid-binding globulin in humans","volume":"91","author":"Nader","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bbcan.2026.189694_bb0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.exger.2024.112431","article-title":"The effect of tamoxifen on estradiol, SHBG, IGF-1, and CRP in women with breast cancer or at risk of developing breast cancer: a meta-analysis of randomized controlled trials","volume":"191","author":"Li","year":"2024","journal-title":"Exp. Gerontol."},{"issue":"2","key":"10.1016\/j.bbcan.2026.189694_bb0275","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/S0301-2115(01)00398-0","article-title":"Long-term effects of continuous oral and transdermal estrogen replacement therapy on sex hormone binding globulin and free testosterone levels","volume":"99","author":"Serin","year":"2001","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"issue":"2","key":"10.1016\/j.bbcan.2026.189694_bb0280","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s10549-010-1223-2","article-title":"The impact of an aromatase inhibitor on body composition and gonadal hormone levels in women with breast cancer","volume":"125","author":"van Londen","year":"2011","journal-title":"Breast Cancer Res. Treat."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189694_bb0285","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1158\/1078-0432.CCR-06-2086","article-title":"Obesity and sex steroids during gonadotropin-releasing hormone agonist treatment for prostate cancer","volume":"13","author":"Smith","year":"2007","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189694_bb0290","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1093\/ije\/dyz107","article-title":"Sex hormone binding globulin and risk of breast cancer: a Mendelian randomization study","volume":"48","author":"Dimou","year":"2019","journal-title":"Int. J. Epidemiol."},{"issue":"5","key":"10.1016\/j.bbcan.2026.189694_bb0295","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1158\/1055-9965.EPI-04-0721","article-title":"Association of breast cancer risk with a common functional polymorphism (Asp327Asn) in the sex hormone-binding globulin gene","volume":"14","author":"Cui","year":"2005","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"issue":"12","key":"10.1016\/j.bbcan.2026.189694_bb0300","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1093\/jnci\/djh167","article-title":"Polymorphisms associated with circulating sex hormone levels in postmenopausal women","volume":"96","author":"Dunning","year":"2004","journal-title":"J. Natl. Cancer Inst."},{"issue":"4","key":"10.1016\/j.bbcan.2026.189694_bb0305","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1080\/01635580903441279","article-title":"Dietary isoflavone intake, polymorphisms in the CYP17, CYP19, 17beta-HSD1, and SHBG genes, and risk of breast cancer in case-control studies in Japanese, Japanese Brazilians, and non-Japanese Brazilians","volume":"62","author":"Iwasaki","year":"2010","journal-title":"Nutr. Cancer"},{"issue":"8","key":"10.1016\/j.bbcan.2026.189694_bb0310","doi-asserted-by":"crossref","first-page":"8307","DOI":"10.1007\/s11033-012-1680-2","article-title":"Association between SHBG Asp327Asn (rs6259) polymorphism and breast cancer risk: a meta-analysis of 10,454 cases and 13,111 controls","volume":"39","author":"Zhou","year":"2012","journal-title":"Mol. Biol. Rep."},{"issue":"12","key":"10.1016\/j.bbcan.2026.189694_bb0315","doi-asserted-by":"crossref","first-page":"3490","DOI":"10.1158\/1055-9965.EPI-08-0734","article-title":"Studies in, T. Risks of cancer heredity, identification of common variants in the SHBG gene affecting sex hormone-binding globulin levels and breast cancer risk in postmenopausal women","volume":"17","author":"Thompson","year":"2008","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"issue":"4","key":"10.1016\/j.bbcan.2026.189694_bb0320","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25042182","article-title":"Sex-hormone-binding globulin gene polymorphisms and breast cancer risk in Caucasian women of Russia","volume":"25","author":"Ponomarenko","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.bbcan.2026.189694_bb0325","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines12040818","article-title":"Obesity-dependent association of the rs10454142 PPP1R21 with breast cancer","volume":"12","author":"Ponomarenko","year":"2024","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189694_bb0330","first-page":"121","article-title":"Genetic variation in estrogen and progesterone pathway genes and breast cancer risk: an exploration of tumor subtype-specific effects","volume":"26","author":"Nyante","year":"2015","journal-title":"Cancer Causes Control"},{"issue":"2","key":"10.1016\/j.bbcan.2026.189694_bb0335","doi-asserted-by":"crossref","DOI":"10.4238\/gmr.15028640","article-title":"Genetic polymorphisms and haplotype of hormone-related genes are associated with the risk of breast cancer in Chinese women","volume":"15","author":"Pan","year":"2016","journal-title":"Genet. Mol. Res."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189694_bb0340","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1210\/endo-129-1-75","article-title":"Biological effects of sex hormone-binding globulin on androgen-induced proliferation and androgen metabolism in LNCaP prostate cells","volume":"129","author":"Damassa","year":"1991","journal-title":"Endocrinology"},{"issue":"10","key":"10.1016\/j.bbcan.2026.189694_bb0345","doi-asserted-by":"crossref","first-page":"4126","DOI":"10.1210\/endo.137.10.8828467","article-title":"Stimulation of prostate cancer growth by androgens and estrogens through the intermediacy of sex hormone-binding globulin","volume":"137","author":"Nakhla","year":"1996","journal-title":"Endocrinology"},{"issue":"7","key":"10.1016\/j.bbcan.2026.189694_bb0350","doi-asserted-by":"crossref","first-page":"3179","DOI":"10.1210\/en.2012-1011","article-title":"Selective cleavage of human sex hormone-binding globulin by kallikrein-related peptidases and effects on androgen action in LNCaP prostate cancer cells","volume":"153","author":"Sanchez","year":"2012","journal-title":"Endocrinology"},{"issue":"9","key":"10.1016\/j.bbcan.2026.189694_bb0355","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/0039-128X(92)90102-F","article-title":"Receptor for sex steroid-binding protein of endometrium membranes: solubilization, partial characterization, and role of estradiol in steroid-binding protein-soluble receptor interaction","volume":"57","author":"Fortunati","year":"1992","journal-title":"Steroids"},{"issue":"5","key":"10.1016\/j.bbcan.2026.189694_bb0360","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1530\/eje.0.1380574","article-title":"Effect of medroxyprogesterone acetate on sex hormone-binding globulin mRNA expression in the human endometrial cancer cell line Ishikawa","volume":"138","author":"Misao","year":"1998","journal-title":"Eur. J. Endocrinol."},{"issue":"1\u20132","key":"10.1016\/j.bbcan.2026.189694_bb0365","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.mce.2004.11.005","article-title":"Sex hormone-binding globulin antagonizes the anti-apoptotic effect of estradiol in breast cancer cells","volume":"230","author":"Catalano","year":"2005","journal-title":"Mol. Cell. Endocrinol."},{"issue":"5","key":"10.1016\/j.bbcan.2026.189694_bb0370","doi-asserted-by":"crossref","first-page":"156","DOI":"10.3892\/ol.2020.12017","article-title":"Therapeutic effect of metformin in the treatment of endometrial cancer","volume":"20","author":"Mu","year":"2020","journal-title":"Oncol. Lett."},{"issue":"1\u20133","key":"10.1016\/j.bbcan.2026.189694_bb0375","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0960-0760(99)00092-8","article-title":"Estradiol induction of cAMP in breast cancer cells is mediated by foetal calf serum (FCS) and sex hormone-binding globulin (SHBG)","volume":"70","author":"Fortunati","year":"1999","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"1\u20132","key":"10.1016\/j.bbcan.2026.189694_bb0380","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0303-7207(01)00725-0","article-title":"O-Glycosylation of human sex hormone-binding globulin is essential for inhibition of estradiol-induced MCF-7 breast cancer cell proliferation","volume":"189","author":"Raineri","year":"2002","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.bbcan.2026.189694_bb0385","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.lfs.2018.06.024","article-title":"Fibulin-1 interacts with Sex Hormone Binding Globulin and is linked to less aggressive estrogen-dependent breast cancers","volume":"207","author":"Marano","year":"2018","journal-title":"Life Sci."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189694_bb0390","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/cdd.2015.119","article-title":"Novel p53 target genes secreted by the liver are involved in non-cell-autonomous regulation","volume":"23","author":"Charni","year":"2016","journal-title":"Cell Death Differ."},{"issue":"7","key":"10.1016\/j.bbcan.2026.189694_bb0395","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0039-128X(93)90088-5","article-title":"Genistein is an effective stimulator of sex hormone-binding globulin production in hepatocarcinoma human liver cancer cells and suppresses proliferation of these cells in culture","volume":"58","author":"Mousavi","year":"1993","journal-title":"Steroids"},{"issue":"4","key":"10.1016\/j.bbcan.2026.189694_bb0400","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1210\/jcem-64-4-825","article-title":"Sex hormone-binding globulin secretion by human hepatocarcinoma cells is increased by both estrogens and androgens","volume":"64","author":"Lee","year":"1987","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189694_bb0405","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.gendis.2021.10.003","article-title":"Sex hormone-binding globulin impedes hepatocellular carcinoma growth via MERTK regulation","volume":"9","author":"Lee","year":"2022","journal-title":"Genes Dis."},{"issue":"9","key":"10.1016\/j.bbcan.2026.189694_bb0410","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1007\/s00109-025-02569-2","article-title":"Sex hormone-binding globulin restrains hepatic fibrosis via inhibition of Tgfbeta expression","volume":"103","author":"Lee","year":"2025","journal-title":"J. Mol. Med."},{"issue":"8","key":"10.1016\/j.bbcan.2026.189694_bb0415","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1093\/carcin\/bgz107","article-title":"Sex hormone-binding globulin suppresses NAFLD-triggered hepatocarcinogenesis after menopause","volume":"40","author":"Lee","year":"2019","journal-title":"Carcinogenesis"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189694_bb0420","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.mce.2012.01.027","article-title":"Weight gain increases human aromatase expression in mammary gland","volume":"355","author":"Chen","year":"2012","journal-title":"Mol. Cell. Endocrinol."},{"issue":"2","key":"10.1016\/j.bbcan.2026.189694_bb0425","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/00042192-200512020-00016","article-title":"Adipose aromatase gene expression is greater in older women and is unaffected by postmenopausal estrogen therapy","volume":"12","author":"Misso","year":"2005","journal-title":"Menopause"},{"issue":"22","key":"10.1016\/j.bbcan.2026.189694_bb0430","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222212557","article-title":"Dietary intake of 17alpha-Ethinylestradiol promotes HCC progression in humanized male mice expressing sex hormone-binding globulin","volume":"22","author":"Lee","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.bbcan.2026.189694_bb0435","first-page":"C1685","article-title":"Sex hormone-binding globulin dampens growth and metastasis of breast cancer in an estrogen-independent manner","volume":"328","author":"Lee","year":"2025","journal-title":"Am. J. Phys. Cell Phys."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189694_bb0440","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1515\/BC.2000.027","article-title":"The first laminin G-type domain in the SHBG-like region of protein S contains residues essential for activation of the receptor tyrosine kinase sky","volume":"381","author":"Evenas","year":"2000","journal-title":"Biol. Chem."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189694_bb0445","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/S0014-5793(97)00448-1","article-title":"Roles of gamma-carboxylation and a sex hormone-binding globulin-like domain in receptor-binding and in biological activities of Gas6","volume":"408","author":"Tanabe","year":"1997","journal-title":"FEBS Lett."},{"issue":"16","key":"10.1016\/j.bbcan.2026.189694_bb0450","doi-asserted-by":"crossref","DOI":"10.1002\/mnfr.202200125","article-title":"Effect of resveratrol content in red wine on circulating sex hormone-binding globulin: lessons from a pilot clinical trial","volume":"66","author":"Brianso-Llort","year":"2022","journal-title":"Mol. Nutr. Food Res."},{"issue":"34","key":"10.1016\/j.bbcan.2026.189694_bb0455","doi-asserted-by":"crossref","first-page":"25920","DOI":"10.1074\/jbc.M004484200","article-title":"Steroid-binding specificity of human sex hormone-binding globulin is influenced by occupancy of a zinc-binding site","volume":"275","author":"Avvakumov","year":"2000","journal-title":"J. Biol. Chem."},{"issue":"9","key":"10.1016\/j.bbcan.2026.189694_bb0460","doi-asserted-by":"crossref","first-page":"3203","DOI":"10.1021\/jm049087f","article-title":"Successful in silico discovery of novel nonsteroidal ligands for human sex hormone binding globulin","volume":"48","author":"Cherkasov","year":"2005","journal-title":"J. Med. Chem."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X26001666?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X26001666?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:18:27Z","timestamp":1789517907000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304419X26001666"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":92,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S0304419X26001666"],"URL":"https:\/\/doi.org\/10.1016\/j.bbcan.2026.189694","relation":{},"ISSN":["0304-419X"],"issn-type":[{"value":"0304-419X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sex hormone-binding globulin as a context-dependent regulator of sex steroid bioavailability in cancers","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Reviews on Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbcan.2026.189694","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"189694"}}